These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19325497)

  • 21. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS;
    Am J Psychiatry; 2017 Nov; 174(11):1086-1093. PubMed ID: 29088928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalproex extended-release in acute bipolar II depression.
    Wang PW; Nowakowska C; Chandler RA; Hill SJ; Nam JY; Culver JL; Keller KL; Ketter TA
    J Affect Disord; 2010 Jul; 124(1-2):170-3. PubMed ID: 19923006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
    J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
    Kemp DE; Gao K; Fein EB; Chan PK; Conroy C; Obral S; Ganocy SJ; Calabrese JR
    Bipolar Disord; 2012 Nov; 14(7):780-9. PubMed ID: 23107222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL; Cunanan C
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
    Delbello MP; Schwiers ML; Rosenberg HL; Strakowski SM
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1216-23. PubMed ID: 12364843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
    Geller B; Luby JL; Joshi P; Wagner KD; Emslie G; Walkup JT; Axelson DA; Bolhofner K; Robb A; Wolf DV; Riddle MA; Birmaher B; Nusrat N; Ryan ND; Vitiello B; Tillman R; Lavori P
    Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.
    Delbello MP; Kowatch RA; Adler CM; Stanford KE; Welge JA; Barzman DH; Nelson E; Strakowski SM
    J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):305-313. PubMed ID: 16540815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study.
    Kakkar AK; Rehan HS; Unni KE; Gupta NK; Chopra D; Kataria D
    Eur Psychiatry; 2009 Apr; 24(3):178-82. PubMed ID: 19324530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM; Baker JD; Wozniak P; Tracy K; Sommerville KW
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.